Monopar Therapeutics director Christopher M. Starr disposes of USD 672,243 in common shares
Bitget2026/10/05 21:44Director Christopher M. Starr cut his direct stake in Monopar Therapeutics to 5,173 common shares on Oct. 1, 2026. Disposed of 8,400 shares via option exercise at $0.005, then sold 8,400 shares at weighted-average prices of $78.09, $78.82, $79.67. Also reported 9,880 shares held indirectly through a revocable trust, bringing total beneficial ownership to 15,053 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monopar Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-032048), on October 05, 2026, and is solely responsible for the information contained therein.
- Director Christopher M. Starr cut his direct stake in Monopar Therapeutics to 5,173 common shares on Oct. 1, 2026.
- Disposed of 8,400 shares via option exercise at $0.005, then sold 8,400 shares at weighted-average prices of $78.09, $78.82, $79.67.
- Also reported 9,880 shares held indirectly through a revocable trust, bringing total beneficial ownership to 15,053 shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Eurozone Sentix Investor Confidence Index slips to 2.4 in November from 2.7 in October


SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.

Quantumrail Cancels 10 Billion Won Convertible Bond Offering